심혈관질환용 디지털 헬스 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Digital Health For Cardiovascular Market Summary

The global digital health for cardiovascular market size was valued at USD 50.2 billion in 2025 and is projected to grow from USD 59.0 billion in 2026 to USD 158.9 billion by 2033, at a CAGR of 15.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 38.1% in 2025. The rising prevalence of cardiovascular diseases and the demand for continuous, technology-enabled care are accelerating the adoption of digital health solutions for cardiovascular management.

Technologies such as remote patient monitoring, wearable devices, mobile health applications, telecardiology, and AI-enabled diagnostic platforms enable early disease detection, ongoing monitoring, and personalized treatment.

These tools help healthcare providers improve disease management, increase patient engagement, and ease the strain on traditional healthcare systems.

Global Digital Health For Cardiovascular Market Report Segmentation

This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of industry trends in each sub segment from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global digital health for cardiovascular market on the basis of component, end-use and region:

• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Software
• Hardware
• Services
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Patients
• Providers
• Payers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Thailand
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. End Use outlook
• 2.3. Competitive Insights

Chapter 3. Global Digital Health for Cardiovascular Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. Global Digital Health for Cardiovascular: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's five forces analysis
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Trend Analysis
• 3.5. Case Study Insights

Chapter 4. Global Digital Health for Cardiovascular Market Segment Analysis, By Component, 2021 - 2033 (Revenue in USD Million)

• 4.1. Definition and Scope
• 4.2. Component Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Digital Health for Cardiovascular Market, by Component, 2021 to 2033
  • 4.4.1. Hardware
    • 4.4.1.1. Hardware Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 4.4.2. Software
    • 4.4.2.1. Software Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 4.4.3. Services
    • 4.4.3.1. Services Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 5. Global Digital Health for Cardiovascular Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Digital Health for Cardiovascular Market, by End Use, 2021 to 2033
• 5.5. Patients
  • 5.5.1. Patients market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Providers
  • 5.6.1. Providers market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Payers
  • 5.7.1. Payers market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts, 2021 to 2033 (USD million)

Chapter 6. Digital Health for Cardiovascular Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Digital Health for Cardiovascular Market Share by Region, 2025 & 2033:
• 6.5. North America
  • 6.5.1. North America digital health for cardiovascular market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Scenario
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Scenario
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Scenario
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe digital health for cardiovascular market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Scenario
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Scenario
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Scenario
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Scenario
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Scenario
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Scenario
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Scenario
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Scenario
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Scenario
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Scenario
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. U.S. Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Scenario
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Scenario
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Scenario
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Scenario
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Scenario
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Scenario
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Scenario
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Scenario
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Scenario
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Scenario
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait Digital Health for Cardiovascular Market, 2021 To 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Profiles
  • 7.4.1. Apple, Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Orange Business
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Epic Systems Corporation
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. NXGN Management, LLC.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Siemens Healthineers AG
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. GE HealthCare
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. CardiAI
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Cardiologs
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. UltraSight
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. HeartVista Inc. (Vista.ai)
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Viz.ai, Inc.
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. RSIP Vision
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Cleerly, Inc.
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives